Pharma / Science / Tech / AI – A mix of News | 13 July 2018

A blend of posts old and new that are in no particular order.  As new posts come in others will head to archives. 

Hope you enjoy reading!

#medicaldevice  #newsmedical  #medicalnews  #medicaltech  #technology #healthcare  #pharma

Latest!  News Medical | |  The latest medical device news from News Medical |  13 July 2018 Edition


  • Device / Technology News: New ‘Leadless’ Pacemakers Less Likely to Cause Complications, Research Finds
  • Device / Technology News: Titan Enterprises announces expansion of offerings with RS Components
  • Health & Personal Care:  UB-511 Wrist Blood Pressure Monitor from A&D MedicalUB-511 Wrist Blood Pressure Monitor from A&D Medical
  • WHITEPAPER:  Simplified DNA Quantification and Normalization
  • Health & Personal Care:  UM-201 Professional Blood Pressure Monitor from A&D Medical
  • Medical Devices:  EVA 500D Digital Colposcope from Sonologic
  • Medical Devices:  PachPen Handheld Pachymeter from Keeler
  • Health & Personal Care:   UM-102 Mercury Free Sphygmomanometer from A&D Medical

Read the articles listed above by following this link  >>>

Please visit the ‘News-Medical website where you will be able to opt-in for varying health related newletters  >>> © 2000-2018
Privacy Terms and Conditions

#clinicaltrial  #Phase1 #Norovirus  #Vaccine  #biotech 

Norovirus vaccine: Oral tablet Phase 1 clinical trial results published |  Outbreak News Today  |  PRESS RELEASE  |  13 July 2018

Opening paragraph:

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced publication of the comprehensive results of the previously disclosed Phase 1 clinical trial with its norovirus oral tablet vaccine in the Journal of Clinical Investigation Insight.

For more news and articles visit the ‘Outbreak News Today’ website via this link  >>>


#LymeDisease  #UnitedStates  #CitizenScientistStudy  #Ticks

Ticks found in 83 counties where not previously recorded: Citizen-Scientist Study  |  Outbreak News Today  |  PRESS RELEASE  12 July 2018

A leading nonprofit funder of innovative Lyme disease research in the U.S., the  Bay Area Lyme Foundation, announced the results of the first citizen-scientist study to evaluate the prevalence of disease-carrying ticks throughout the United States.

This study was undertaken via a partnership between the Northern Arizona University and the  Colorado State University The study published in the peer-review journal PLOS ONE, the study is based on a massive sample of more than 16,000 ticks collected from 49 U.S. states and Puerto Rico.

Read the article via this link  >>>

For more news and articles visit the ‘Outbreak News Today’ website via this link  >>>


Morning Rounds


Celebrate the 2018 Warren Alpert Foundation Prize recipients and their commitment to research | STAT: Morning Rounds  |  13 July 2018

Vertex Pharmaceutical’s Paul Negulescu leads a team of scientists whose relentless research has led to transformational precision medicines to treat the underlying cause of cystic fibrosis. Congratulations to Paul and all the 2018 Warren Alpert Foundation Prize recipients for their passion and pioneering contributions to research. Learn more about CF research.

Link to STAT: Morning Rounds  |  13 July 2018  >>>

STAT: Morning Rounds ~ DOJ fentanyl crackdown, drug shortages, & spice-loving tree shrews


#virtualreality  #psychologicaltherapy  #mentalhealth  #phobias  #fears

Automated virtual reality-based psychological therapy may help reduce fear of heights  |  Lancet  | 12 July 2018

Opening lines:

Psychological therapy delivered by a virtual reality coach can help people with a clinically diagnosed fear of heights overcome their fear, according to a randomised controlled trial of 100 people published in The Lancet Psychiatry journal.

Read more via this link  >>>

Sourced via >>>



Massive genome havoc in breast cancer is revealed
Long-read sequencing enabled the team to reconstruct in great detail the history of how the HER2 gene gets massively amplified in HER2-positive breast cancer cells, says Dr. Schatz. Top rectangle shows a 2 million base-pair segment of chromosome 17 occupied by the HER2 gene (also called ERBB2). A small segment of the gene, already massively amplified, breaks off and fuses with chromosome 8 (lower rectangle). On that chromosome, parts of the gene are copied as many as 1000 times, with various segments jumping around within the chromosome (green arcs). This shows why we want to identify HER2-positive patients as early as possible, to prevent the kind of chaos that we register here cumulatively, says Schatz. Credit: Schatz Lab, CSHL/JHU

Massive genome havoc in breast cancer is revealed  |  Cold Spring Harbor Laboratory  12 July 2018

Sourced via >>>


Data scientists in hot demand thanks to Big Data  |  Fraunhofer-Gesellschaft  |  02 July 2018

Dr. Andreas Jedlitschka, Fraunhofer IESE, explains in an interview why data scientists are in such demand today. Credit: Fraunhofer IESE

3D-printed living tissues could spell the end of arthritis | by Ethan Bilby | Horizon Magazine | 02 July 2018


Where do AI and oncology converge? | ERIN DIETSCHE | MedCity News | 01 July 2018

The MedCity CONVERGE conference in Philadelphia on July 11-12 will take a closer look at how companies like Deep 6 AI are making their mark at the intersection of artificial intelligence and cancer care.

Where do AI and oncology converge?

Meet the ‘preeminent AI company on earth,’ but can it succeed in healthcare? | HEALTH ITMEDICAL DEVICES | MedCity News | 01 July 2018 

Nvidia holds a dominant position in terms of making the chips that power artificial intelligence projects, but can the Silicon Valley tech company with roots in the world of gaming and graphics succeed in healthcare?

Meet the ‘preeminent AI company on earth,’ but can it succeed in healthcare?

For more Medtech, AI, Science, Healthcare and Pharma news visit the MedCity Website where you can also opt-in for e-newsletters >>>



eyeforpharma logo

#pharmanews #eyeforpharma #pharma #tech

Why MSLs And Sales Reps Should Join Forces | Katie Osborne  | eyeforpharma |  26 June 2018

The case for aligning MSLs with sales reps is strong — if both sides play ball.

Artificial Intelligence: The Counter-Argument |  Adam Chapman | eyeforpharma |  7 June 2018

AI is being touted as the doctor’s new lifeline — we put this proposition to a skeptical doctor.

Sizing Up Pharma’s Tech Maturity |  | eyeforpharma |  1 June 2018


eyeforpharma Editorial Disclaimer
The views and opinions expressed in our content are those of the authors and do not necessarily reflect the official policy or position of eyeforpharma. Examples of analysis performed within this article are only examples. Assumptions made within the analysis are not reflective of the position of eyeforpharma.

Get the latest industry insights in your inbox:

Follow eyeforpharma on Twitter:

Like eyeforpharma on Facebook:

Subscribe to eyeforpharma youtube channel:


Some picks from my co-editor Rie 

Credit: National Cancer Institute


BCG vaccine leads to long-term blood sugar improvement in type 1 diabetes patients  |   Massachusetts General Hospital |  21 June 2018


‘Long-term follow-up of participants in clinical trials of a generic vaccine to reverse advanced type 1 diabetes finds significant clinical benefits, including restoration of near-normal blood sugar levels.’ 

Read more via this link  >>>


MIT scientists discover fundamental rule of brain plasticity
A dendrite and its spines, reconstructed with electron microscopy (right) after it was imaged with two-photon microscopy in the intact brain (left). Credit: Mriganka Sur, et. al.

Scientists discover fundamental rule of brain plasticity | Picower Institute at MIT  |  21 June 2018

Taken from opening paragraph:

‘In a new study in Science, researchers at the Picower Institute for Learning and Memory at MIT demonstrate for the first time how this balance is struck: when one connection, called a synapse, strengthens, immediately neighboring synapses weaken based on the action of a crucial protein called Arc.’


Thank you Rie 🙂


FibroFlutters continuously

Advocating for a Multi-Disciplinary approach to all aspects of medical healthcare. With a model approach using all the ‘stakeholders’ I’ve designed a patient’s perspective of what patient-centred care, patient-included, patient-involved, patient-centric should look like and involve, that’s everyone by the way! 

You all need to pitch in!!

Siemens Healthineers

New!  Which one is the right breast biopsy technique?  | Newsletter | 28 June 2018

If you can’t see it, you can’t biopsy it
Every biopsy technique has its strenghts and weaknesses

Which one is the right breast biopsy technique?

NEW online magazine channel 

#clinical professional #healthcare manager #pharma

News & Stories: In-depth information – convincing facts and figures
Explore an online magazine tailored to the needs of healthcare managers and clinical professionals

Siemens Healthineers
Shared knowledge and cross-border collaboration are shaping tomorrow’s world of diagnostics and therapy. The new online magazine channel, News & Stories, features knowledge and experiences shared by clinical professionals as well as valuable market insights in healthcare.
News & Stories provides you with this valuable knowledge.

Siemens Healthineers ~ News & Stories – Online magazine channel 

This email was sent by:
Siemens Healthcare GmbH | Henkestr. 127, 91052 Erlangen, Germany

Information for healthcare professionals. The Siemens Healthineers newsletter and websites, including but not limited to and its affiliated sites, provide an online resource for healthcare professionals

“PatientsLikeMe is the world’s largest personalized health network that helps people findnew treatment options, connect with others and take action to improve their outcomes.”

I am Proud to be a member and Ambassador of

@patientslikeme the world’s largest personalized health network
helping 600,000+ people with 2,800+ conditions find new options for treatments, connect with others and take action to improve their outcomes.

Join for free on!

Come and find me @scraf73

A chance to change the future of personalized health.

@patientslikeme (twitter)


#technews #technology #amputees #prosthetica #medicaldevice #medicalinnovation #mobility #disabled 

New 'e-dermis' brings sense of touch, pain to prosthetic hands
Engineers at the Johns Hopkins University have created an electronic skin and aim to restore the sense of touch through the fingertips of prosthetic hands. Credit: Larry Canner/JHU


New ‘e-dermis’ brings sense of touch, pain to prosthetic hands | Johns Hopkins University  | 20 June 2018

Excerpt / Quote:

‘”After many years, I felt my hand, as if a hollow shell got filled with life again,” says the anonymous amputee who served as the team’s principal volunteer tester.’

Read the article via this link >>> 

New ‘e-dermis’ brings sense of touch, pain to prosthetic hands

Other tech news via Tech Xplore  >>>

Technology news


#technews #technology #exoskeleton #paraplegic #medicaldevice #medicalinnovation #mobility #disabled 


Credit: Wandercraft

Exoskeleton designed to help paraplegics walk |  Nancy Owano | Tech Xplore | 14 June 2018

Opening paragraph:

‘An exoskeleton that can restore mobility for people confined to wheelchairs is always met with interest by medical professionals and by those affected. This time around, a lot of interest is evidenced in a team’s effort to provide an exoskeleton that does not require the use of crutches.’

Read more via this link  >>>

Exoskeleton designed to help paraplegics walk

Other tech news via Tech Xplore  >>>

Technology news



#tumormetabolism #cancerdrugs #cancer #TrinityCollegeDublin #science #research 

Credit: CC0 Public Domain

Scientists show that drugs targeting tumor metabolism will not stop natural killer cells | Trinity College Dublin  |  14 June 2018


‘NK cells are immune cells that play an important role in our defence against cancer, as they can directly kill tumour cells. Once activated, NK cells increase their intake of fuels and generate more energy, which facilitates a boost in their tumour-killing capabilities. The new research shows that activated NK cells do not use glutamine, a fuel commonly used by cancer cells, to generate energy.’

Read more via this link  >>>

Follow this link to find out about Trinity College in Dublin  >>>

Other tech news via Tech Xplore  >>>

Technology news

#PHARMA #pharma #pharmanews #pharmaphorum

#medicalinnovation #blockchain #healthcare #nanotechnology #medicine #realworld

Deep Dive Magazine ~ Future Pharma 2018| Pharmaphorum  | 6  June 2018

“As pharma’s model is increasingly disrupted, how will health care and drug development progress? Click the button to read our preview article from the Medicines Discovery Catapult.” Quoted from the cover

What you can read about via the link below  >>>

  • Chris Molloy, Medicines Discovery Catapult, explains why the future of medical innovation lies with the industry’s SMEs
  • Karen Taylor, Deloitte, offers six predictions for the course of our industry into 2022, both evolutionary and revolutionary
  • How Blockchain could enable a truly global healthcare ecosystem
  • And a look into real-world examples of how nanotechnology is now advancing medicine, and the challenges faced
  • Sign up here to ensure you receive our next Deep Dive Oncology special reportfrom ASCO when it is published at the end of this month, and future issues free on publication.You can read our previous editions here: Deep Dive: Patient CentricityDeep Dive Market Access II.

If you like what you see then you can subscribe to the ‘Deep Dive’ magazine and daily updates via the Pharmaphorun website.

Link to the magazine >>>

Sign up for the pharmaphorum daily newsletter and /or the ‘Deep Dive’ magazine via this link  >>>

Kind regards
Adam Jeffery
Commercial Director, Deep Dive
Copyright © 2018 pharmaphorum media limited, All rights reserved. 
Subscribed to receive Deep Dive via registration form.

A fabulous pharma magazine!


#clinicalresearch #patients #patientparticipation #clinicaltrials #painmedicine #futureofpharma #whywedoresearch

Patients, Power, Participation: How Enrolling in Clinical Trials Can Help Ensure That The Future of Pain Medicine is Now | SKILLFULLY WELL & PAINFULLY AWARE | KATARINA ZULAK  | 7 June 2018


‘Participants in clinical trials have the opportunity to access cutting-edge therapies before they are made widely available, often at leading medical facilities. Experimental treatments can be appealing to individuals who have failed to benefit from conventional treatments. There is no cost to participate in medical research and health insurance is not required. Additionally, some studies compensate individuals who join the clinical trial.’

About Katarina  >>>

This piece has been entered in the Patients Have Power Writing Contest run by Clara Health designed to raise awareness about clinical trials.

Visit the homepage for more blog posts by Katarina >>>


#biopharma #pharma #FDA

BioPharma Dive Daily edition | 02 July​ 2018

Headlines  >>>

  • Novartis set to threaten Mylan’s EpiPen franchise
  • Tecentriq extends streak with win in breast cancer trial
  • In FDA first, Dermira secures approval for excessive sweating drug
  • Biopharma embracing real-world evidence, report says
  • Celgene gets key Phase 3 win with anemia drug
  • Galapagos posts ‘underwhelming’ cystic fibrosis results, boosting Vertex


How to complete clinical trials 22% faster

Learn how cloud computing and similar technologies can adapt to trial volatility, thus enhancing efficiency and saving pharma companies millions of dollars. Download available

Read all the above via the following link >>>

About BioPharma Dive
Our mission is to provide busy execs like you with an overview of the BioPharma industry in 60 seconds. BioPharma Dive is a product of Industry Dive.
View other Industry Dive publications.


 eyeforpharma logo

Upcoming events

view all events


Get your brochure via my post here >>>

Brochures available! Patient Summit-London & the ‘Patient Summit’ Philadelphia events in October | eyeforpharma / Impatient

 More information in a post below


Eyeforpharma – Mission statement:
Our mission is to make pharma more open and valued.
The ultimate driver for the pharmaceutical industry’s health is meeting the needs of patients, otherwise it will cease to matter. For healthcare to be as good as it could be, the strength, skills and resources of our industry need to be fully integrated into health outcomes and we need pharma experience at the decision-making table.
We believe the industry must focus on a business model combining service with product, with patients at the center.



#digitalhealthnews #digitalhealth #AI #analytics #digitalpatient

#clinicalsoftware #sharedrecocords #healthCIO #LHCRE #digitalNHS

New WHITEPAPER!  Thought Leadership Mailer – How Population Health Management will deliver a sustainable NHS ( GGI & IBM Watson Health ) | Digital Health Newsletter | Digital Health | 29 June 2018

Digital Health Newsletter | Digital Health | 29 June 2018

Link to the newsletter and links to other news sections >>>

Headlines  >>>

FEATURE | Is Windows 10 really the answer to NHS cyber-insecurities?

FEATURE | The GDE knowledge-sharing challenge and the blueprinting process

INFRASTRUCTURE | King’s Fund report says digital change being driven locally

AI AND ANALYTICS  |  IBM and Karantis360 team up for IoT assisted living system

DIGITAL PATIENT |  NHS to record private healthcare data to address gaps in health records

DIGITAL PATIENT |  Private clinicians urged to approve performance data ahead of publication

Link to their homepage on WordPress where you can read more digital health news and opt-in for newsletters  >>>

Registered No. 9257440 | Vat No. 198 3531 71

Im-patient UPDATE 

Thankyou to everyone…

…who has participated in the design of ‘Impatient’-London event in October, and the ‘Impatient’ Philadelphia event also in October.

You can now take a look at the brochures for ‘Patient Summit Europe’, ‘Patient Summit USA’ and book your places via the following links >>>

At Patient Summit Europe 2018 (October 16-17) we will be bursting the patient centricity bubble; challenging pharma and patients to come together in true partnership and discover a real shift to solution-based thinking.

Highlights from the agenda include  >>>

  • im-patient” – a new feature in 2018, half a day designed, created and hosted by our patient steering committee
  • Industry leading case studies, including IMI’s Big Data for Better Outcomes, Novartis’s “EPALCO” and Merck Group’s “MS in the 21st Century” projects
  • Co-presentations between pharma and patients, including Janssen, Pfizer and more
  • Interactive roundtables on both days dedicated to the topics patients want to discuss with pharma most

Key themes  >>>

  • Patient Critical = Business Critical – Recognize that patient value translates to business value – maximize social benefits to maximize your performance
  • Clear the clinical bottleneck – Reimagine your clinical trials through innovative patient focused design and the removal of antiquated endpoints
  • Work with patients, not for patients – Co-create solutions with patients in order to generate maximum uptake
  • Informed patients are stronger partners – Promote health literacy to build an educated patient population who can supercharge your efforts

FREE PASS for #Patients who are unaffiliated with pharma business and consultancy. 

All pharma or solution providers who book via me for Patient Summit Europe can have the advantage of a €200 discount.

 Patient Summit Europe

At London 2018 (October 16-17)

Get your copy of the brochure now – for the full details of the agenda and “im-patient” summit.

 Patient Summit USA

At Philadelphia 2018 (October 23-24)

Get your copy of the brochure now – for the full details of the agenda and “im-patient” summit.

The Im-Patient Summit - Logo

#NOTjustPatients #socialmedianetwork #digitalhealth #advocacyplatform #MAYOclinic #MCSMN

Mayo Clinic Social Media Network (MCSMN)


There’s access to discussions, webinars & MCSMN Blog  depending on membership selection from Free, or, Premium.  Please note that e-patients and students receive a special rate.

Carole Scrafton ~ CEO FibroFlutters / Founding Five Member & Rie my co-editor are both members, so if you join you can connect with us!


Do you think this is a network for you?, or maybe you know someone else who might benefit from it’s services?

You can join the MCSMN via the following link >>>

  • That here at we are not medical professionals just fellow chronic illness warriors sharing information.
  • Any information read or shared on, to or from this blog site should not override any advice given to you by your own Doctors.
  • FibroFlutters is not a selling site but we will point you in the direction to subscribe to newsletters/magazines and some offer free, some don’t! 
  • Do not take any work, articles or pages to be your own, including those from third partie, or any external partie links, and always accredit the appropriate authors accordingly.
  • Always speak to your GP first before stopping, changing or trying new medications or treatments, FibroFlutters will not claim responsibility for any loss or damage from third parties/third partie links, or any external parties..
  • Always be aware of Internet security and note that we cannot be held responsible for external websites.
  • Remember that buying products such as ‘cure-claiming’ remedies on-line can be a risky business and again FibroFlutters will not claim responsiblity for any loss or damage from third parties/third partie links or any external parties.

MANY THANKS in advance for your understanding –

from the administrator – fibrofly73


FibroFlutters continuously

Advocating for a Multi-Disciplinary approach to all aspects of medical healthcare. With a model approach using all the ‘stakeholders’ I’ve designed a patient’s perspective of what patient-centred care, patient-included, patient-involved, patient-centric should look like and involve, that’s everyone by the way! 

You all need to pitch in!!

Many thanks POSTER butterfly

Wish to stay informed? please sign-up for e-mail alerts